Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 14, 2014; 20(22): 6786-6808
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6786
Colorectal cancer: From prevention to personalized medicine
Gemma Binefa, Francisco Rodríguez-Moranta, Àlex Teule, Manuel Medina-Hayas
Gemma Binefa, Cancer Prevention and Control Program, Catalan Institute of Oncology, IDIBELL, CIBERESP, Hospitalet de Llobregat, 08908 Barcelona, Spain
Gemma Binefa, Department of Clinical Sciences, University of Barcelona, Hospitalet de Llobregat, 08908 Barcelona, Spain
Francisco Rodríguez-Moranta, Endoscopy Unit, University Hospital of Bellvitge, IDIBELL, CIBERESP, Hospitalet de Llobregat, 08908 Barcelona, Spain
Àlex Teule, Genetic Counseling Unit, Catalan Institute of Oncology, Hospitalet de Llobregat, 08908 Barcelona, Spain
Manuel Medina-Hayas, Department of Morphological Sciences, Universitat Autonoma de Barcelona, Bellaterra, 08193 Barcelona, Spain
Author contributions: All of the authors contributed in each phase of the paper (design, acquisition and interpretation of data); all authors revised the draft of the manuscript and approved the final version.
Supported by Partially funded by the Carlos III Health Institute No. PI11/01593
Correspondence to: Gemma Binefa, MD, MPH, Cancer Prevention and Control Program, Catalan Institute of Oncology, IDIBELL, CIBERESP, Hospitalet de Llobregat, Av. Gran Via 199-203, 08908 Barcelona, Spain. gbinefa@iconcologia.net
Telephone: +34-93-2607351 Fax: +34-93-2607956
Received: September 28, 2013
Revised: January 16, 2014
Accepted: March 6, 2014
Published online: June 14, 2014
Core Tip

Core tip: Although there are different strategies for screening, the number of which is increasing due to the potential of emerging technologies in molecular marker application, not all strategies meet the criteria required for screening tests in population programs; the three most accepted tests are fecal occult blood test, colonoscopy and sigmoidoscopy.